| Product Code: ETC11530636 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Companion Diagnostic Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Companion Diagnostic Market - Industry Life Cycle |
3.4 Ghana Companion Diagnostic Market - Porter's Five Forces |
3.5 Ghana Companion Diagnostic Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Ghana Companion Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ghana Companion Diagnostic Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Ghana Companion Diagnostic Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 Ghana Companion Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ghana Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Ghana |
4.2.2 Growing awareness about personalized medicine and targeted therapies |
4.2.3 Government initiatives to improve healthcare infrastructure and services |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities in remote areas of Ghana |
4.3.2 Lack of skilled healthcare professionals for interpreting companion diagnostic results |
4.3.3 High costs associated with companion diagnostic tests |
5 Ghana Companion Diagnostic Market Trends |
6 Ghana Companion Diagnostic Market, By Types |
6.1 Ghana Companion Diagnostic Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Ghana Companion Diagnostic Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Ghana Companion Diagnostic Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Ghana Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry, 2021 - 2031F |
6.1.5 Ghana Companion Diagnostic Market Revenues & Volume, By Next-Gen Sequencing, 2021 - 2031F |
6.1.6 Ghana Companion Diagnostic Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.2 Ghana Companion Diagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ghana Companion Diagnostic Market Revenues & Volume, By Drug Response Testing, 2021 - 2031F |
6.2.3 Ghana Companion Diagnostic Market Revenues & Volume, By Biomarker Testing, 2021 - 2031F |
6.2.4 Ghana Companion Diagnostic Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.5 Ghana Companion Diagnostic Market Revenues & Volume, By Disease Identification, 2021 - 2031F |
6.3 Ghana Companion Diagnostic Market, By Disease Area |
6.3.1 Overview and Analysis |
6.3.2 Ghana Companion Diagnostic Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Ghana Companion Diagnostic Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.3.4 Ghana Companion Diagnostic Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.5 Ghana Companion Diagnostic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4 Ghana Companion Diagnostic Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Ghana Companion Diagnostic Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Ghana Companion Diagnostic Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Ghana Companion Diagnostic Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Ghana Companion Diagnostic Market Revenues & Volume, By Urine, 2021 - 2031F |
6.5 Ghana Companion Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Ghana Companion Diagnostic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Ghana Companion Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5.4 Ghana Companion Diagnostic Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Ghana Companion Diagnostic Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
7 Ghana Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Ghana Companion Diagnostic Market Export to Major Countries |
7.2 Ghana Companion Diagnostic Market Imports from Major Countries |
8 Ghana Companion Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostic technologies in Ghanaian healthcare facilities |
8.2 Number of partnerships between local healthcare providers and international diagnostic companies |
8.3 Rate of reimbursement for companion diagnostic tests by healthcare insurance providers in Ghana. |
9 Ghana Companion Diagnostic Market - Opportunity Assessment |
9.1 Ghana Companion Diagnostic Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Ghana Companion Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ghana Companion Diagnostic Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.4 Ghana Companion Diagnostic Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.5 Ghana Companion Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ghana Companion Diagnostic Market - Competitive Landscape |
10.1 Ghana Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Ghana Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here